Modest physical activity lowers CVD risk in older adults

04.12.20151576
Engaging in even modest physical activity was associated with lower risk for CHD, stroke and CVD in older adults, according to the results of a prospective cohort study.

Novel oral anticoagulants may reduce stroke, bleeding risk in patients with renal impairment

03.12.20151600
In patients with mild or moderate renal impairment, the use of novel oral anticoagulants appears to confer reduced risks for stroke or systemic embolism, as well as for major bleeding, compared with warfarin, according to research published in The American Journal of Cardiology.

Fatty liver disease increases risk for impaired myocardial perfusion

02.12.20151576
Patients undergoing primary PCI for STEMI who present with moderate or severe fatty liver disease were more likely to have impairment of myocardial perfusion compared with patients with less severe disease, according to recent findings.

FDA approves rosuvastatin for use in youth aged 8 to 17 with HeFH

01.12.20151509
AstraZeneca announced that the FDA has approved rosuvastatin to reduce total cholesterol, LDL and apolipoprotein B in pediatric patients aged 8 to 17 years with heterozygous familial hypercholesterolemia.

Rivaroxaban associated with more GI bleeding than warfarin; fatal GI bleeds rare

30.11.20151546
Compared with warfarin, rivaroxaban was associated with increased gastrointestinal bleeding, according to new data from the ROCKET AF trial.

Premenstrual syndrome may confer elevated risk for hypertension

25.11.20151546
Women with moderate-to-severe premenstrual syndrome had a 40% increased risk for hypertension later in life compared with women with few or no menstrual symptoms in a recent study.

CardioBrief: At-Home Statin Intolerance Test Faces Skeptics Experts question role for the genetic test, now promoted direct to consumers

24.11.20150
A small laboratory company, Boston Heart Diagnostics, has introduced and is promoting direct to consumers "the first and only at-home saliva laboratory developed test," which it says will help identify people who are likely to experience side effects from taking a statin.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.